Patentable Inventions. In case any Inventions are patentable:
Patentable Inventions. Genentech shall be responsible, at its sole discretion and expense, for filing, prosecuting, and maintaining Genentech Gene Patents, Project Patents and, following designation of a Protein Candidate, any Lexicon Pre-Existing Patents and Restricted Rights Project Patents (to the extent exclusively licensed to Genentech) related to such Protein Candidate.
Patentable Inventions. (a) As between Capital One and First Data, First Data shall have exclusive ownership of Patent Rights in patentable inventions, and all patentable improvements to such inventions, to the extent that such inventions or improvements were conceived and reduced to practice by one or more employees of First Data (collectively the “First Data Inventions”).
Patentable Inventions. (1) Negotiation of a Commercial License. SYSTEM, through TAES, has granted CERES in the SRA a time-limited option to obtain an exclusive world-wide commercial license in SYSTEM’s rights in Subject Inventions under the SRA, with the right to grant sublicenses. If CERES advises SYSTEM as per the terms of the SRA that CERES elects to obtain an exclusive commercial license to such Subject Invention, the Parties shall initiate negotiation of a license agreement based on the Example License Agreement for Subject Inventions in Appendix A. The start of such negotiations shall be evidenced by written notice from one Party to the other initiating such negotiations, and such negotiations shall not extend beyond one hundred eighty (180) days from the start thereof without the mutual consent of both Parties (“Negotiation Period”). Such license shall be negotiated in good faith between the Parties and shall contain reasonable business terms common to CERES’ field of commercial interest and proposed application. If the Parties fail to reach agreement within the Negotiation Period, the terms and conditions of the license on which no agreement was reached shall be settled in accordance with the following procedures: the disputed contract terms shall be referred to a mutually agreed impartial expert whose decision shall be final. Each Party shall submit to the expert within fifteen (15) days of his appointment its position in writing on the disputed contract terms and conditions. Such expert shall be limited to choosing one of such two (2) party positions on each of the contract terms and conditions or related group of contract terms and conditions that the expert considers most reasonable in the circumstances and shall not make any other determination. Neither Party shall be bound by any determination by the expert which, in the opinion of Party’s counsel, will result or be likely to result in that Party violating any applicable law or regulation.
Patentable Inventions. Unless otherwise agreed to by the parties in any license or other agreement, all patentable inventions, improvements and any patent rights appurtenant thereto, conceived and reduced to practice pursuant to the Research shall be owned jointly where created jointly or solely by each party where so created. Licenses to any such inventions, improvements and patent rights, however owned, shall be governed by the terms of this Agreement and/or any future license agreement pertaining to such rights.
Patentable Inventions. Lexicon shall be responsible, at its sole discretion and expense, for filing, prosecuting, and maintaining Lexicon Knock-Out Technology, Lexicon Pre-
Patentable Inventions. The Parties hereby agree that all --------------------- Program Know-How shall be ***. If a patentable invention is conceived in the course of the Program, Lilly and Albany shall discuss that invention and the desirability of filing a United States patent application covering the invention, as well as any foreign counterparts. Lilly shall make the final decision on whether a patent application should be filed on such invention. In the event Lilly determines that a patent application should be filed on such invention, Albany shall file and prosecute the application. If an invention is made jointly pursuant to 35 U.S.C. (S)116, Lilly shall make the decision on whether a patent application covering such joint invention should be filed. In the event Lilly determines that a patent application should be filed on such joint invention, Lilly shall file and prosecute the application. All patent applications and patents covering any invention made under the Program shall be owned by the Parties or Party, as the case may be, that own(s) said invention.
Patentable Inventions. Inventions conceived of and reduced to practice during the Contract Period solely by Lilly shall be the property of Lilly. Inventions conceived of and reduced to practice during the Contract Period solely by ICAgen shall be the property of ICAgen. Inventions conceived of and reduced to practice during the Contract Period jointly by one or more employees of ICAgen and one or more employees of Lilly shall be jointly owned by ICAgen and Lilly.
Patentable Inventions. Unless otherwise agreed to by the parties in any license or other agreement, all patentable inventions, improvements and any patent rights appurte- nant thereto, conceived and reduced to practice pursuant CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. to the Research shall be owned jointly where created jointly or solely by each party where so created. Licenses to any such inventions, improvements and patent rights, however owned, shall be governed by the terms of this Agreement and/or any future license agreement pertaining to such rights.
Patentable Inventions. (1) Negotiation of a Commercial Exploitation License. SYSTEM, through AGRILIFE, has granted CERES in the ARSRA an option to obtain an exclusive world-wide commercial exploitation license in SYSTEM’s rights in Subject Inventions under the ARSRA, with the right to grant sublicenses. If CERES exercises such option pursuant to the terms of the ARSRA, the Parties shall initiate negotiation of a license agreement based on the Example License Agreement for Subject Inventions in Appendix A and the Parties shall comply with the good faith negotiation process and timelines set forth in the ARSRA.